Merck plans to divest French research site by end 2008 - report |
|
|
|
Published
:
Thu, 29 Nov 2007 08:59
|
PARIS (Thomson Financial) - Merck's prescription division, Merck Serono, plans to divest its French research centre at Chilly-Mazarin, Les Echos reported.The move follows the German pharmaceutical company's decision to focus on products prescribed by specialists, the paper said, citing Pierre-Henry Longeray, managing director of Merck Serono France.The company said it has already had contact with a number of companies but has not yet begun the sale process.The site, its last remaining research centre in France, employs 104 researchers and technicians, Les Echos said.helen.beresford@thomson.comhem/ms1COPYRIGHTCopyright Thomson Financial News Limited 2007. All rights reserved.The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
|
|
|
|
Print this Story
Merck licenses Protiva R&D technology 